Effectiveness of a Psychoeducation and Support Protocol by Phone in the Aid of Caregivers of Patients With Dementia.

January 10, 2020 updated by: Hospital de Clinicas de Porto Alegre

Randomized Clinical Assessment to Evaluate the Effectiveness of a Psychoeducation and Support Protocol by Telephone, in the Aid of Caregivers of Patients With Dementia in Specialized Ambulatory Accompanying

Dementias are neurodegenerative syndromes typical of the elderly population and causing a high degree of disability and sick of dependence on others for care. Caregivers of patients with dementia, especially those belonging to the same family suffer with high overhead and is often affected by losses in their own health. The aim of this study is to evaluate the efficacy of a psychoeducation and protocol support, conducted by telephone, in aid of patients with dementia caregivers in specialized outpatient treatment. It will be selected patients in outpatient specialized care. The primary outcome is the change in Zarit Scale.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Dementias are neurodegenerative syndromes typical of the elderly population and cause a high degree of incapacity and dependence of the patient in relation to the care of others. Caregivers of patients with dementia, especially those belonging to the same family, suffer from a high degree of overload, and are often affected by impairments in their own health. Previous studies have shown that telephone interventions for the assistance and guidance of these individuals have a positive impact on their own quality of life as well as on the family members under their care. Measures like this can also optimize specialized services and facilitate the search for medical help when needed.

In this way, the present study aims to evaluate the efficacy of a psychoeducation and support protocol, performed by telephone, to assist caregivers of patients with dementia under specialized outpatient follow-up.

Patients will be divided into two groups. Participants in the intervention group, in addition to the usual primary health care, will receive weekly telephone contacts over a period of eight weeks, previously scheduled with psychoeducational guidelines and support in the management of their relatives and with dementia. The control group will receive the usual follow-up at the in primary health care. Both group will received a prited materials about problematic behavior.

Considering the prevalence and impact of dementia syndromes, it is necessary to conduct studies that are directed at reducing the burden and promoting the information and care of the caregivers of patients with dementia, also providing an improvement in the quality of care. The present project brings as scientific contribution an innovative approach to the reality of our country, with great potential to become an alternative, cost-effective and easily accessible measure for the assistance of people with dementia and their relatives and caregivers.

Study Type

Interventional

Enrollment (Anticipated)

148

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Porto Alegre, Brazil, 90035903
        • Recruiting
        • Hospital de Clinicas de Porto Alegre
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • home caregivers
  • female and of the same family as the patient
  • dementia of any etiology and severity
  • caregivers should be responsible for the patient for at least 40 hours per week and for a -minimum period of 6 months
  • must have at least 4 years of formal study

Exclusion Criteria:

  • caregivers with physical limitations that prevent the application of research instruments
  • patients with significant functional impairment related to other diseases
  • plans by the caregiver to place the patient in a long-term home in the next 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Telesupport: eight weekly phone calls of psychoeducation and support on the illness of their relatives. Patients will also receive printed materials on problematic behaviors about dementia.
In the intervention will be carried out eight weekly phone calls of psychoeducation and support on the disease of the relatives approaching different themes.
No Intervention: Control
No active intervention. Patients will only receive printed materials on problematic behaviors about dementia and no contact by the research team.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in the caregiver's level of burden
Time Frame: Week 9
Zarit Burden Interview
Week 9
Change from baseline in the caregiver's level of burden
Time Frame: Week 18
Zarit Burden Interview
Week 18

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in the caregivers's depressive symptoms
Time Frame: Week 9
Beck Depression Inventory
Week 9
Change from baseline in the caregivers's depressive symptoms
Time Frame: Week 18
Beck Depression Inventory
Week 18
Change from baseline in the caregivers's anxiety symptoms
Time Frame: Week 9
Beck Anxiety Inventory
Week 9
Change from baseline in the caregivers's anxiety symptoms
Time Frame: Week 18
Beck Anxiety Inventory
Week 18
Change from baseline in the caregivers's quality of life
Time Frame: Week 9
Quality of Life Questionnaire - WHOQOL
Week 9
Change from baseline in the caregivers's quality of life
Time Frame: Week 18
Quality of Life Questionnaire - WHOQOL
Week 18
Change from baseline in the presence and severity of neurosypsychiatric symptoms in the patient
Time Frame: Week 9
Neuropsychiatric Inventory - NPI
Week 9
Change from baseline in the presence and severity of neurosypsychiatric symptoms in the patient
Time Frame: Week 18
Neuropsychiatric Inventory - NPI
Week 18
Change from baseline in the patient functionality
Time Frame: Week 9
Pfeffer Functional Activities Questionnaire
Week 9
Change from baseline in the patient functionality
Time Frame: Week 18
Pfeffer Functional Activities Questionnaire
Week 18

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Artur S Schuh, PhD, Federal University of Rio Grande do Sul

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2017

Primary Completion (Anticipated)

April 15, 2020

Study Completion (Anticipated)

June 20, 2020

Study Registration Dates

First Submitted

August 16, 2017

First Submitted That Met QC Criteria

August 23, 2017

First Posted (Actual)

August 24, 2017

Study Record Updates

Last Update Posted (Actual)

January 14, 2020

Last Update Submitted That Met QC Criteria

January 10, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Telesupport

Subscribe